The Dexcom Global Registry study is exploring how people use the Dexcom Continuous Glucose Monitoring (CGM) System in everyday life. This system helps check blood sugar levels continuously. The study collects data on how the system is used and its effects, both looking back at past data (retrospective) and gathering new data moving forward (prospective).
Key Points:
- Participants need to be able to use the Dexcom CGM System as directed.
- You must have had a Hemoglobin A1c test (a test that shows average blood sugar levels over the past 3 months) before starting the study.
- Participants need to see their healthcare provider at least twice a year and complete some surveys.
To join, you should be ready to follow the study rules and provide written consent, unless there's an approved waiver. If you have any conditions that make the Dexcom CGM unsuitable for you, you might not be able to participate. The study doesn't require you to take any new treatments, but you need to use the Dexcom system as instructed.
How understandable was the trial content above?
Hard to understand
Easy to understand